CINECA IRIS Institutional Research Information System

BOCCHIO CHIAVETTO, LUISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.273
EU - Europa 6.582
AS - Asia 1.425
AF - Africa 247
SA - Sud America 40
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 3
Totale 16.592
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.149
RU - Federazione Russa 3.377
DE - Germania 1.479
CN - Cina 727
UA - Ucraina 608
SG - Singapore 548
SE - Svezia 282
CM - Camerun 236
GB - Regno Unito 233
IT - Italia 144
FI - Finlandia 132
FR - Francia 129
CA - Canada 118
IE - Irlanda 93
TR - Turchia 86
PL - Polonia 77
BR - Brasile 27
EU - Europa 22
IN - India 15
IL - Israele 8
MX - Messico 6
ES - Italia 5
IR - Iran 5
PE - Perù 5
VN - Vietnam 5
HK - Hong Kong 4
HU - Ungheria 4
ID - Indonesia 4
MA - Marocco 4
AR - Argentina 3
AT - Austria 3
BE - Belgio 3
JP - Giappone 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AU - Australia 2
BD - Bangladesh 2
EC - Ecuador 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
RO - Romania 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
KE - Kenya 1
KR - Corea 1
LY - Libia 1
MN - Mongolia 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 16.592
Salva come PNG Salva come JPEG
Città #
Fairfield 1.564
Woodbridge 699
Seattle 694
Ashburn 680
Houston 661
Beijing 636
Cambridge 604
Jacksonville 559
Chandler 539
Wilmington 504
Moscow 304
Ann Arbor 213
Singapore 156
The Dalles 110
Ottawa 106
Boardman 103
Chicago 95
Dublin 90
Lawrence 90
Princeton 86
New York 70
Kraków 65
Helsinki 64
Rome 61
San Diego 49
London 48
Saint Petersburg 35
Portsmouth 27
Yubileyny 25
Los Angeles 22
Lauterbourg 19
Frankfurt am Main 18
Nanjing 17
Norwalk 16
Prescot 16
Cedar Knolls 13
Kunming 13
Redwood City 13
Chiswick 12
Guangzhou 12
Düsseldorf 10
Milan 10
Hefei 9
Islington 9
Kilburn 9
San Francisco 9
Dearborn 8
Hounslow 8
Falls Church 7
Mcallen 7
Wroclaw 7
Atlanta 5
Chengdu 5
Mexico City 5
Nanchang 5
Redmond 5
Roubaix 5
St Louis 5
Dallas 4
Hanoi 4
New Bedfont 4
Shanghai 4
Toronto 4
Warsaw 4
West Jordan 4
Brooklyn 3
Brussels 3
Hong Kong 3
Istanbul 3
Jinan 3
Kocaeli 3
Rimini 3
Santa Clara 3
Segrate 3
Shenyang 3
Sotto 3
São Paulo 3
Almaty 2
Ankara 2
Assago 2
Barcelona 2
Behshahr 2
Bexley 2
Boston 2
Chennai 2
Garden City 2
Guarulhos 2
Hanover 2
Ibitinga 2
Jackson 2
Johannesburg 2
Lake Forest 2
Miami Beach 2
Mumbai 2
Novara 2
Palermo 2
Paris 2
Rio de Janeiro 2
Serrata 2
Stockholm 2
Totale 9.346
Salva come PNG Salva come JPEG
Nome #
The -1727 A/T, -50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms and resistance to antipsychotics in schizophrenia 432
Immune and metabolic alterations in first episode psychosis (FEP) patients 366
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 315
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients 277
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 276
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis 273
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects 272
Allelic variation in the human prodynorphin gene promoter and schizophrenia 253
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients 248
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 244
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. 244
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 242
Effetti biomolecolari del maltrattamento infantile: il ruolo dell'epigenetica e dell'infiammazione 239
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease 238
Aspetti biologici e neuropsicologici del maltrattamento e abuso infantili 236
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study 234
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 233
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid 228
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses 226
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 224
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 223
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia 220
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 220
Glucose metabolism alterations in patients with bipolar disorder 218
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence 218
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs 216
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients 215
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 214
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study 214
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. 213
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 212
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia 211
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 210
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor 207
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 206
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 206
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 203
Season of birth and inflammatory response system in schizophrenia 202
Markers of Alzheimer's disease in a population attending a memory clinic 201
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment 201
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients 200
Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study 199
Blood microRNA changes in depressed patients during antidepressant treatment 199
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 199
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 196
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter 194
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 194
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review 193
G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 193
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease 191
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 190
VEGF serum levels in depressed patients during SSRI antidepressant treatment 190
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 188
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 186
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics 186
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases 183
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 181
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 181
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 176
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects 168
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 158
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 154
Association study of-1727 A/T,-50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms with schizophrenia 149
Gene-environment interaction in major depression: focus on experience-dependent biological systems 144
CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors 143
Association study and meta-analysis of-308 A/G functional polymorphism in TNF alpha gene with schizophrenia 143
Association between IL-1 cluster and IL-10 gene polymorphisms and schizophrenia 143
Association between IL-1 beta-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia 143
Association study between -1727A/T, -50C/T and (CAA)(N) repeat GSK-3beta gene polymorphisms and Bipolar Disorder 139
The cytokine network genes and resistance to antipsychotics in schizophrenia 136
Influence of G1730A polymorphism of estrogen receptor beta gene on brain morphology in postmenopausal women 134
Evidence in Support of the AD Biomarker Dynamic Model from a Memory Clinic Naturalistic Series of Patients with Mild Cognitive Impairment 131
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 130
Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state 126
Serum brain derived neurotrophic factor concentrations in attention deficit hyperactivity disorder (ADHD) 125
Serum and plasma BDNF levels in major depression: Replication study plus meta-analysis 124
Childhood trauma and glucose metabolism in patients with first-episode psychosis 122
miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity 115
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study 112
Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease. 110
Molecular mechanisms of brain stimulation. (Chapter 11). 107
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 95
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 91
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 77
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup. 76
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 61
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations 60
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 55
P.264 Association of single nucleotide polymorphisms in the 3’ untranslated region of SLC1A2 with major depressive disorder and relative endophenotypes 52
Vascular endothelial growth factor (VEGF) serum: putative predictive biomarkers for the electroconvulsive therapy (ECT) in depressed patients 40
Reduction of oxytocin plasma levels in borderline personality disorder and normalization induced by psychotherapies 15
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 9
Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of "Psychobiotics" 6
null 5
null 2
null 1
null 1
null 1
Totale 16.752
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.924
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020118 0 0 0 0 0 0 0 0 0 0 0 118
2020/20212.814 322 294 248 400 288 243 322 142 125 116 247 67
2021/2022598 108 59 128 46 9 21 21 139 33 23 8 3
2022/20231.614 176 11 11 221 167 344 1 230 299 43 87 24
2023/2024558 27 40 62 68 59 86 21 10 0 16 5 164
2024/20254.171 34 22 18 3 113 319 2.282 779 302 62 183 54
Totale 16.752